Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Operating Income (2020 - 2025)

iSpecimen has reported Operating Income over the past 6 years, most recently at -$2.7 million for Q4 2025.

  • Quarterly results put Operating Income at -$2.7 million for Q4 2025, up 53.98% from a year ago — trailing twelve months through Dec 2025 was -$9.0 million (up 29.46% YoY), and the annual figure for FY2025 was -$9.0 million, up 29.46%.
  • Operating Income for Q4 2025 was -$2.7 million at iSpecimen, up from -$2.8 million in the prior quarter.
  • Over the last five years, Operating Income for ISPC hit a ceiling of -$942644.0 in Q1 2021 and a floor of -$5.8 million in Q4 2024.
  • Median Operating Income over the past 5 years was -$2.3 million (2022), compared with a mean of -$2.4 million.
  • Biggest five-year swings in Operating Income: crashed 401.15% in 2021 and later skyrocketed 53.98% in 2025.
  • iSpecimen's Operating Income stood at -$2.0 million in 2021, then decreased by 7.35% to -$2.1 million in 2022, then plummeted by 34.06% to -$2.9 million in 2023, then crashed by 103.43% to -$5.8 million in 2024, then skyrocketed by 53.98% to -$2.7 million in 2025.
  • The last three reported values for Operating Income were -$2.7 million (Q4 2025), -$2.8 million (Q3 2025), and -$1.8 million (Q2 2025) per Business Quant data.